Isosibiricin inhibits microglial activation by targeting the dopamine D1/D2 receptor-dependent NLRP3/caspase-1 inflammasome pathway. [electronic resource]
Producer: 20201023Description: 173-180 p. digitalISSN:- 1745-7254
- Animals
- Caspase 1 -- metabolism
- Cell Line
- Dose-Response Relationship, Drug
- Inflammasomes -- drug effects
- Inflammation -- drug therapy
- Lipopolysaccharides
- Mice
- Mice, Inbred BALB C
- Microglia -- drug effects
- NLR Family, Pyrin Domain-Containing 3 Protein -- metabolism
- Receptors, Dopamine D1 -- metabolism
- Receptors, Dopamine D2 -- metabolism
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.